NCT05733091
- Conditions
- Neoplasms, Tumors
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Tumors
Explore clinical trials studying Tumors. Study availability and eligibility vary by location and protocol.
110 public trials
6 recruiting studies
Tumors trial results
Recruiting
HP Pyruvate MRI in Cancers
NCT05697406
- Conditions
- Image, Neoplasms, Tumors, +1 more
- Locations
-
- University of Maryland Medical Center Baltimore, Maryland, United States
NCT04341181
- Conditions
- Cancer, Neoplasia, Neoplasms, +1 more
- Locations
-
- Aalborg University Hospital Aalborg, Denmark
- Aarhus University Hospital Aarhus, Denmark
- Rigshospitalet Copenhagen, Denmark
- Herlev Hospital Herlev, Denmark
Recruiting
Cohort of Tumors With POLE/D1 Mutation
NCT05103969
- Conditions
- Neoplasms, POLD1 Gene Mutation, POLE Exonuclease Domain Mutation, +1 more
- Locations
-
- CHU -hopital Rangeuil Toulouse, France
Recruiting
The Drug Rediscovery Protocol (DRUP Trial)
NCT02925234
- Conditions
- Cancer, Neoplasia, Neoplasm, +2 more
- Locations
-
- Noordwest ziekenhuisgroep Alkmaar (NWZ) Alkmaar, Netherlands
- Ziekenhuisgroep Twente Almelo, Netherlands
- Meander medisch centrum Amersfoort, Netherlands
- Netherlands Cancer Institute Amsterdam, Netherlands
Recruiting
XACT ACE Observational Registry
NCT04950959
- Conditions
- Neoplasms, Tumors
- Locations
-
- Lahey Hospital and Medical Center Burlington, Massachusetts, United States
Active, not recruiting
Perioperative Risk Study
NCT02456389
- Conditions
- Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +7 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT02275910
- Conditions
- Neoplasms, Tumors
- Locations
-
- Eisai Trial Site #1 Nagoya, Aichi-ken, Japan
- Eisai Trial Site #1 Kashiwa, Chiba, Japan
- Eisai Trial Site #1 Matsuyama, Ehime, Japan
- Eisai Trial Site #1 Sapporo, Hokkaido, Japan
NCT06945432
- Conditions
- FAPI, FDG PET/CT, Neoplasms, +2 more
- Locations
-
- The Second Hospital of Lanzhou University Lanzhou, Gansu, China
Completed
CDK4/6 Tumor, Abemaciclib, Paclitaxel
NCT04594005
- Conditions
- Neoplasms, Tumors
- Locations
-
- Severance Hospital Seoul, South Korea